Fairbanks Pharmaceuticals

Curing diabetes through beta cell repair and regeneration

Search for:

Tonight is the Challenge Pitch-off for the M2D2 $200K Challenge, and Fairbanks will be there competing as one of 20 finalists.

Check out the interview with CEO Alan Schneyer published on the M2D2 site today!

Fairbanks Pharmaceuticals is developing transformative diabetes therapies that address the underlying cause of diabetes.

Fairbanks Wins Boston Innovation Prize “Golden Ticket”
Boehringer Ingelheim (BI) and the BI Venture Fund have awarded Fairbanks Pharmaceuticals the prestigious 2018 Boston Innovation Prize “Golden Ticket.” The prize recognizes the challenge … Continue reading Fairbanks Wins Boston Innovation Prize “Golden Ticket” →
Phase II SBIR Award Kickoff Meeting
With a Phase II SBIR award in hand, Fairbanks Pharmaceuticals CEO Alan Schneyer and team are moving quickly to execute the project plan and achieve … Continue reading Phase II SBIR Award Kickoff Meeting →

Enter your email address to get occasional updates with our latest news.

Email Address

158 Laurel St
Concord MA 01742

Baystate Research Facility 3601 Main St, 2nd Floor Springfield MA 01199